# 2026-06906: FDA Asks for Input on Device Approval Paperwork

2026-06906, Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Approval of Medical Devices, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-04-10, effective Either electronic or written comments on the collection of information must be submitted by June 9, 2026.; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-06906
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-06906
- Title: Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Approval of Medical Devices
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 18468
- Published: 2026-04-10
- Effective: Either electronic or written comments on the collection of information must be submitted by June 9, 2026.
- Comments close: 2026-06-09
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA Asks for Input on Device Approval Paperwork

## Summary

The FDA wants your thoughts on how it collects info for approving new medical devices before they hit the market. This affects device makers who must provide detailed info to prove their products are safe and effective. You’ve got until June 9, 2026, to share your comments, helping shape a smoother, clearer approval process without extra costs or delays.

## Abstract

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collection associated with premarket approval of medical devices.

## Effects PRIA read

- Large Increase in PMA Compliance Hours: cost, high. If you make Class III medical devices and submit Premarket Approval (PMA) applications, FDA estimates total annual burden for this information collection at 1,182,316 hours. FDA says the overall reporting burden estimate rose by about 244%, driven by more frequent submissions like PMA amendments an…
- Pediatric Use Info Must Be Submitted: cost, medium. PMA applicants must provide pediatric-use information under section 515A of the FD&C Act, including a description of pediatric subpopulations and the number of affected pediatric patients. FDA included pediatric information burden in its estimate (pediatric items total 8,306 hours annually).
- ClinicalTrials.gov Certification Required (Form FDA 3674): cost, low. Certain PMA applications must be accompanied by a certification under 42 U.S.C. 282(j)(5)(B) using Form FDA 3674, and should include National Clinical Trial numbers where available. FDA estimates the annual burden for these certifications at 46 hours total.
- Electronic eSTAR Submissions — Setup and Savings: mixed, low. FDA encourages use of the eSTAR electronic submission template. FDA says eSTAR should significantly reduce submission burden, but it included initial eSTAR setup burden in its estimate (9,174 setup submissions at 0.08 hours each, totaling 734 hours annually).
- Recordkeeping Burden for PMA Holders Increased: cost, medium. Applicants with approved PMAs must maintain records used to trace patients and ensure continued safety; FDA estimates 860 active PMAs with recordkeeping averaging 17 hours per recordkeeper for a total of 29,240 hours annually. FDA reports recordkeeping burden rose about 212%.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-06906 on federalregister.gov](https://www.federalregister.gov/documents/2026/04/10/2026-06906/agency-information-collection-activities-proposed-collection-comment-request-premarket-approval-of)
- [2026-06906 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-04-10/pdf/2026-06906.pdf)

## Related
- [Previous: 2026-06905, Clean Air Act Operating Permit Program; Order on Petition for Objection To Stat…](https://policyrisk.com/federal-register/2026-06905)
- [Next: 2026-06910, Clean Air Act Operating Permit Program; Order on Petition for Objection to Stat…](https://policyrisk.com/federal-register/2026-06910)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-06906 (as of 2026-06-08).
